Publications by authors named "Knut Wendelin"

Claim this Profile
E
Early allogeneic stem cell transplantation after melphalan-induced aplasia leads to long-term survival in patients with primary refractory AML.
Claudius Söhn, Kerstin Schäfer-Eckart, Knut Wendelin, Stefan Knop

Ann Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.
Fabian Lang, Andreas Voss, Guido Kobbe, Christian Junghanss, Joachim Beck, Knut Wendelin

Leuk Lymphoma· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis.
Osama Ahmad, Nicolaus Kröger, Eva Wagner-Drouet, David Nachbaur, Normann Steiner, Knut Wendelin

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL-MODULE phase I study.
Christoph Röllig, Christoph Schliemann, Leo Ruhnke, Lars Fransecky, Björn-Niklas Heydrich, Knut Wendelin

Br J Haematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia.
Nicola Gökbuget, Kristina Ihrig, Michael Stadler, Matthias Stelljes, Ahmet Elmaagacli, Knut Wendelin

Haematologica· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.
Dietrich W Beelen, Renate Arnold, Matthias Stelljes, Nael Alakel, Arne Brecht, Knut Wendelin

Transplant Cell Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment.
Lorenz Bastian, Alina M Hartmann, Thomas Beder, Sonja Hänzelmann, Jan Kässens, Knut Wendelin

Leukemia· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma.
Jan A Stratmann, Aaron Becker von Rose, Sebastian Koschade, Knut Wendelin, Friedemann Köhler

Ann Hematol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spontaneous remission of acute lymphoblastic leukemia: A case report.
Timm Höres, Knut Wendelin, Kerstin Schaefer-Eckart

Oncol Lett· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
Hannes Wandt, Kerstin Schaefer-Eckart, Knut Wendelin, Bettina Pilz, Martin Wilhelm

Lancet· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation.
Nicola Gökbuget, Daniel Stanze, Joachim Beck, Helmut Diedrich, Heinz-August Horst, Knut Wendelin

Blood· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis